Now, a study suggests simple blood test could help predict those who will benefit. The analysis by US biotech Circular ...
The FDA has confirmed that it will convene an advisory committee meeting on 10th June to discuss Eli Lilly’s Alzheimer’s disease candidate donanemab, after announcing a delay to its review earlier ...
Levin, MSc, is President of Medical Communications across Area23 on Hudson, ProHealth, and Trio, as well as the Commercial Medical Communications Champion at IPG Health Network. A twenty-year industry ...
Our round-up of recent biotech financings is headed by a sizeable $200 million third round for Zenas BioPharma, with Cellectis, Reunion Neuroscience, Karius, Context Therapeutics, and Enlaza also ...
For more than 15 years, shortages of critical drugs — from oncology treatments to emergency room and surgical suite essentials — have burdened healthcare systems and compromised patient care and ...
The industry is showing its teeth, as companies have started slashing positions. Ben Hargreaves reviews how the job losses that started earlier in the biotech industry have quickly spread to all areas ...
The death of a young boy with Duchenne muscular dystrophy (DMD) who was treated with Pfizer’s experimental gene therapy in a phase 2 trial has prompted the company to pause dosing in another study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results